NTHL1-related polyposis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:454840OMIM:616415D12.6
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

NTHL1-related polyposis (also called NTHL1-associated polyposis or NAP) is a rare inherited condition that increases the risk of developing multiple polyps in the colon and rectum, as well as certain cancers. It is caused by changes (mutations) in both copies of the NTHL1 gene, which normally helps repair damage to DNA. When this gene does not work properly, errors build up in the DNA of cells, especially in the lining of the colon, leading to the growth of adenomatous polyps — small growths that can become cancerous over time if not removed. People with NTHL1-related polyposis typically develop between 10 and 100 colorectal polyps, usually during adulthood. Beyond colorectal cancer, there is also an increased risk of other cancers, including breast cancer, endometrial (uterine) cancer, bladder cancer, skin tumors (particularly basal cell carcinomas), and possibly other tumor types. The condition was only recently described, so our understanding is still growing. Treatment focuses on regular surveillance with colonoscopies to find and remove polyps before they become cancerous. Surgery to remove part or all of the colon may be needed if polyps are too numerous to manage with colonoscopy alone. Screening for other associated cancers is also recommended. Early detection through genetic testing in at-risk families can significantly improve outcomes by allowing surveillance to begin before cancer develops.

Also known as:

Key symptoms:

Multiple polyps in the colon and rectumColorectal cancerBreast cancerEndometrial (uterine) cancerSkin tumors, especially basal cell carcinomasBladder cancerBlood in the stoolChanges in bowel habitsAbdominal pain or crampingUnexplained weight lossFatigue from anemia due to chronic blood lossHead and neck tumors (less common)

Clinical phenotype terms (15)— hover any for plain English
Adenomatous colonic polyposisHP:0005227MeningiomaHP:0002858Breast carcinomaHP:0003002Colon cancerHP:0003003Bladder neoplasmHP:0009725Endometrial carcinomaHP:0012114Neoplasm of the rectumHP:0100743Ovarian cystHP:0000138Squamous cell carcinomaHP:0002860Pancreatic adenocarcinomaHP:0006725Duodenal adenocarcinomaHP:0006771Non-Hodgkin lymphomaHP:0012539Seborrheic keratosisHP:0031287
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for NTHL1-related polyposis.

View clinical trials →

No actively recruiting trials found for NTHL1-related polyposis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the NTHL1-related polyposis community →

No specialists are currently listed for NTHL1-related polyposis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to NTHL1-related polyposis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open NTHL1-related polyposisForum →

No community posts yet. Be the first to share your experience with NTHL1-related polyposis.

Start the conversation →

Latest news about NTHL1-related polyposis

No recent news articles for NTHL1-related polyposis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How often should I have a colonoscopy, and when should I start?,What other cancers am I at increased risk for, and what screening do I need?,Should my siblings and other family members be tested for NTHL1 mutations?,Are there any medications or lifestyle changes that could help reduce my polyp or cancer risk?,At what point would you recommend surgery to remove part of my colon?,How will this diagnosis affect my children — what is their risk of being carriers or affected?,Are there any clinical trials or new treatments being studied for this condition?

Common questions about NTHL1-related polyposis

What is NTHL1-related polyposis?

NTHL1-related polyposis (also called NTHL1-associated polyposis or NAP) is a rare inherited condition that increases the risk of developing multiple polyps in the colon and rectum, as well as certain cancers. It is caused by changes (mutations) in both copies of the NTHL1 gene, which normally helps repair damage to DNA. When this gene does not work properly, errors build up in the DNA of cells, especially in the lining of the colon, leading to the growth of adenomatous polyps — small growths that can become cancerous over time if not removed. People with NTHL1-related polyposis typically deve

How is NTHL1-related polyposis inherited?

NTHL1-related polyposis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does NTHL1-related polyposis typically begin?

Typical onset of NTHL1-related polyposis is adult. Age of onset can vary across affected individuals.